Board certified in internal medicine, hematology and medical oncology, Dr. Ardeshir-Larijani`s primary clinical focus is thoracic oncology including lung cancer, mesothelioma and thymic tumors. Dr. Ardeshir-Larijani is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University. She is also one of the ECOG-ACRIN trial investigator. Dr. Ardeshir-Larijani’s scholarly and research activities are on new target discovery and defining an immune resistance mechanism in lung cancer. She also has clinical and research interests in thymic epithelial tumors.
Investigative Task Force for Human Rights & Sanctions Accountability has officially unmasked a critical security threat and ethical crisis within Emory University’s Winship Cancer Institute. In a sweeping formal notice served to over 240 university executives, ITFSA revealed that the university is providing a prestigious clinical platform and U.S. residency to Dr. Fatemeh Ardeshir-Larijani, the daughter of one of the Iranian regime’s most powerful and blood-stained sanctioned leaders.
